TREA

97887000 - SIGRID

Follow

Information

  • Trademark
  • 97887000
  • Serial Number
    97887000
  • Filing Date
    April 13, 2023
    2 years ago
  • Transaction Date
    July 03, 2025
    a month ago
  • Status Date
    July 01, 2025
    a month ago
  • Published for Opposition Date
    May 07, 2024
    a year ago
  • Location Date
    July 02, 2024
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    PATEL, SAMIR
  • Attorney Docket Number
    02335-012-4
    Attorney Name
    Bradley L. Cohn
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
SIGRID
Case File Statements
  • GS0051: Dietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceutical preparations and natural remedy preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemical pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients, and not including products primarily for use in the treatment of angina pectoris and high blood pressure; dietary supplements for humans; dietary supplements for the support of healthy blood sugar levels, weight levels, cholesterol levels, blood pressure levels, and energy levels; vitamin supplements; mineral supplements; food supplements; nutritional supplements
  • GS0101: Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated medical devices, and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, and post bariatric surgery patients
Case File Event Statements
  • 3/4/2024 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/17/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/8/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/9/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/4/2024 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/4/2024 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/7/2024 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/7/2024 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/7/2024 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/1/2024 - a year ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/17/2024 - a year ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/7/2024 - a year ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/7/2024 - a year ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/17/2024 - a year ago
    14 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 6/25/2024 - a year ago
    15 - ASSIGNED TO PETITION STAFF Type: APET
  • 6/26/2024 - a year ago
    16 - POST PUBLICATION AMENDMENT - ENTERED Type: CHPB
  • 10/30/2024 - 9 months ago
    18 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/30/2024 - 9 months ago
    21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/30/2024 - 9 months ago
    19 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/30/2024 - 9 months ago
    20 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/2/2024 - a year ago
    17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/1/2025 - a month ago
    23 - SOU EXTENSION 2 FILED Type: EXT2
  • 7/1/2025 - a month ago
    22 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/1/2025 - a month ago
    24 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 7/2/2025 - a month ago
    25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA